These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3110622)

  • 21. A refined kinetic analysis of plasminogen activation by recombinant bovine tissue-type plasminogen activator indicates two interconvertible activator forms.
    Johnsen LB; Ravn P; Berglund L; Petersen TE; Rasmussen LK; Heegaard CW; Rasmussen JT; Benfeldt C; Fedosov SN
    Biochemistry; 1998 Sep; 37(36):12631-9. PubMed ID: 9730836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patent confusion.
    Ashall F; Goate AM
    Nature; 1991 Apr; 350(6319):550. PubMed ID: 2017249
    [No Abstract]   [Full Text] [Related]  

  • 23. Legislation on vitamin D patent makes waves.
    Maddox J
    Nature; 1988 Mar; 332(6161):192. PubMed ID: 3347258
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recombinant murine cell lines, transformed by various vectors based on bovine type 1 papillomavirus and expressing human tissue plasminogen activator. II. Analysis of cell lines, producing recombinant tissue plasminogen activator].
    Aleshkov SB; Ustav MB; Baev AA
    Mol Biol (Mosk); 1994; 28(3):619-25. PubMed ID: 8052253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wellcome versus Genentech result.
    Johnston K
    Nature; 1987 Jul 16-22; 328(6127):189. PubMed ID: 3110626
    [No Abstract]   [Full Text] [Related]  

  • 26. Generic drug manufacturers lose patent protection battle.
    McGourty C
    Nature; 1988 Oct; 335(6193):756. PubMed ID: 3185701
    [No Abstract]   [Full Text] [Related]  

  • 27. Building a fast-track patent portfolio in the UK and Europe.
    Baldock C; Murphy C
    Nat Biotechnol; 1998 Apr; 16(4):385-6. PubMed ID: 9555732
    [No Abstract]   [Full Text] [Related]  

  • 28. More patent troubles about genes.
    Nature; 1994 Dec; 372(6506):485. PubMed ID: 7990908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genentech gets patent protection for tissue plasminogen activator.
    Ezzell C
    Nature; 1988 Jun; 333(6176):790. PubMed ID: 3133565
    [No Abstract]   [Full Text] [Related]  

  • 30. Amgen protects its billion dollar protein.
    Chahine K
    Nat Biotechnol; 1997 Jun; 15(6):496-7. PubMed ID: 9181560
    [No Abstract]   [Full Text] [Related]  

  • 31. Mixed reaction greets new gene patent proposals from Brussels.
    Dickson D
    Nature; 1993 Jan; 361(6410):285. PubMed ID: 8426638
    [No Abstract]   [Full Text] [Related]  

  • 32. Britain reevaluates taxes on patent income.
    Dolgin E
    Nat Med; 2010 Jan; 16(1):13. PubMed ID: 20057407
    [No Abstract]   [Full Text] [Related]  

  • 33. House of Lords is asked to rule on breadth of gene patent coverage.
    Dickson D
    Nature; 1994 Dec; 372(6506):487-8. PubMed ID: 7990909
    [No Abstract]   [Full Text] [Related]  

  • 34. Tissue plasminogen activator in psoriasis.
    Jensen PJ; Baird J; Belin D; Vassalli JD; Busso N; Gubler P; Lazarus GS
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):13S-14S. PubMed ID: 16788619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Local thrombolysis using a combination of RTPA and Lys-plasminogen in ischemia due to a previous thrombosis].
    Marcon JL; Annweiler M; Bonijoly S; Favre E
    J Mal Vasc; 1989; 14(3):265-6. PubMed ID: 2506312
    [No Abstract]   [Full Text] [Related]  

  • 36. Biochemical and preclinical studies on improved thrombolytic therapy. Research contributions during the period 1986-1990.
    Collen D
    Bull Mem Acad R Med Belg; 1992; 147(11-12):441-9. PubMed ID: 1341569
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin patent dispute revisits old biotechnology battleground.
    Fox JL
    Nat Biotechnol; 1997 Apr; 15(4):307. PubMed ID: 9094114
    [No Abstract]   [Full Text] [Related]  

  • 38. [Construction of co-expression plasmid containing tPA and VEGF165 genes and its expression in VSMCs].
    Wu ZJ; Shi D; Luo XD; Li Y; Xie HY; Zheng SS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):161-4. PubMed ID: 15807255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drugs produced by genetic techniques].
    Bicker U
    Verh Dtsch Ges Inn Med; 1990; 96():451-65. PubMed ID: 2128725
    [No Abstract]   [Full Text] [Related]  

  • 40. EPO patient dispute: court battle ends at the start.
    Gershon D
    Nature; 1989 Dec 21-28; 342(6252):846. PubMed ID: 2594071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.